Insulin-like growth factors and liver cancer risk in male smokers

11Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background:The liver is the primary source of circulating insulin-like growth factor (IGF)-I, yet the relation between IGFs and liver cancer is uncertain.Methods:In a case-cohort study within a cohort of 29 133 male smokers we examined associations of serum IGF-I and IGF binding protein (IGFBP)-3 with liver cancer (50 cases).Results:Nonlinear associations between liver cancer and IGF-I and IGFBP-3 were observed (P0.04 and P0.01, respectively), strongest association at lowest levels (odds ratio (OR)0.2, 95% confidence interval (CI)0.1-0.7 for 80 vs 30 ng ml 1 of IGF-I; OR0.2, 95% CI0.1-0.6 for 1400 vs 700 ng ml 1 of IGFBP-3).Conclusions:Low IGF-I and IGFBP-3 levels in male smokers are associated with increased risk of liver cancer. © 2010 Cancer Research UK. All rights reserved.

Cite

CITATION STYLE

APA

Major, J. M., Stolzenberg-Solomon, R. Z., Pollak, M. N., Snyder, K., Virtamo, J., & Albanes, D. (2010). Insulin-like growth factors and liver cancer risk in male smokers. British Journal of Cancer, 103(7), 1089–1092. https://doi.org/10.1038/sj.bjc.6605842

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free